L-Allo-isoleucine - CAS 1509-34-8
Catalog number: 1509-34-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
COA:
Inquire
Targets:
Others
Description:
L-Allo-isoleucine, an amino acid compound, has been found to be probably significant in the study of modulating of blood sugar.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
White to Off-White Solid
Synonyms:
L-allo-Isoleucine; L-Alloisoleucine; (2S,3R)-2-amino-3-methylpentanoic acid; Alloisoleucine; Allo-Isoleucine
Storage:
Store in a cool and dry place and at 0 - 4 °C for short term (days to weeks) or -20 °C for long term (months to years).
MSDS:
Inquire
Quality Standard:
In-house standard
Quantity:
Milligram-Grams
Boiling Point:
225.8ºC at 760mmHg
Melting Point:
-285ºC
Density:
1.035 g/cm3
InChIKey:
AGPKZVBTJJNPAG-UHNVWZDZSA-N
InChI:
InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5+/m1/s1
Canonical SMILES:
CCC(C)C(C(=O)O)N
1.Determination of ten monohydroxylated polycyclic aromatic hydrocarbons by liquid-liquid extraction and liquid chromatography/tandem mass spectrometry.
Fan R1, Ramage R, Wang D, Zhou J, She J. Talanta. 2012 May 15;93:383-91. doi: 10.1016/j.talanta.2012.02.059. Epub 2012 Mar 1.
The aim of this study is to develop and validate an analytical method for the quantitation of ten urinary monohydroxylated polycyclic aromatic hydrocarbons (OH-PAHs) through high pressure liquid chromatography/tandem mass spectrometry (HPLC/MS/MS). After enzymatic deconjugation, urine samples were extracted by liquid-liquid extraction (LLE) and OH-PAHs were analyzed by HPLC/MS/MS operated in negative electrospray ionization (ESI) and multiple reaction monitoring (MRM) mode. LLE was conducted with the solvent mixture of pentane and toluene, which reduced the matrix interferences and enhanced the method sensitivity significantly. Deuterated and (13)C-labeled analogs are used as internal standards. Calibration curves of all target analytes shows favorable linearity within the concentration range of 5.9-15,000.0 ng/L for different OH-PAHs with the regression coefficients above 0.993. The limits of detection (LODs) in pooled urine ranged from 1.
2.High-throughput semi-automated 96-well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood.
Brignol N1, McMahon LM, Luo S, Tse FL. Rapid Commun Mass Spectrom. 2001;15(12):898-907.
A semi-automated high-throughput liquid/liquid extraction (LLE) assay was developed for RAD001 and cyclosporin A (CsA) in human blood. After addition of internal standard and ammonium hydroxide, samples were extracted twice with methyl tert-butyl ether (MTBE). The organic extract was evaporated to dryness and reconstituted in mobile phase. Where possible, sample transfer and LLE steps were automated using a Tomtec Quadra 96 workstation. Samples were analyzed using ESI-LC/MS/MS employing the transitions of ([M + NH(4)](+) --> [M + H](+)) for CsA and ([M + NH(4)](+) --> [M + H-(CH(3)OH + H(2)O)](+)) for RAD001, under isocratic chromatographic conditions (75:25, (v/v), acetonitrile/20 mM ammonium acetate) with a run time of 3.6 min. A lower limit of quantitation (LLOQ) of 0.368 ng/mL and 5.23 ng/mL was achieved for RAD001 and CsA, respectively, using a sample volume of 0.3 mL for the analysis. The method was validated over a 3-day period and the resulting calibration curves had a correlation coefficient >0.
3.Isolation and characterization of insulin from the Brockmann body of Dissostichus mawsoni, an Antarctic teleost fish.
Bachle LA1, Smith DD, Petzel D. J Pept Res. 2000 Jul;56(1):47-54.
The Brockmann body of fish synthesizes and secretes insulin. The Brockmann body of Antarctic fish has been described anatomically and shown to contain insulin immunoreactive sites, however, the primary structure of an Antarctic fish insulin has yet to be reported. Insulin was isolated from the Brockmann bodies of the Antarctic perciform teleost, Dissostichus mawsoni. The peptide was purified to homogeneity by gel filtration and reversed-phase HPLC. Insulin-containing fractions were identified by radioimmunoassay using antisera raised against porcine insulin. Electrospray ionization-mass spectrometry determined the mass of the isolated product to be 5725.27 a.m.u. The amino acid composition and primary structure were determined for the pyridylethylated A- and B-chains. The amino acid sequences of the A chain and B chain were H-Gly-lle-Val-Glu-Gln-Cys-Cys-His-Gln-Pro10-Cys-Asn-Ile-Phe- Asp-Leu-Gln-Asn-Tyr-Cys20-Asn-OH and H-Ala-Pro-Gly-Pro-GIn-His-Leu-Cys-Gly-Ser10-His-Leu-Val-Asp-Ala-Le u-Tyr-Leu-Val-Cys20-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Asn-Pro-Lys30++ +-OH, respectively.
4.Effects of arginase inhibitors on the contractile and relaxant responses of isolated human penile erectile tissue.
Lorenzen JM1, Ückert S, Scheller F, Haller H, Kuczyk MA. World J Urol. 2009 Dec;27(6):805-10. doi: 10.1007/s00345-009-0405-1.
OBJECTIVES: An impairment in the local availability of nitric oxide (NO) may impair male erectile function. The activity of l-arginine-degrading arginase enzymes may attenuate the relaxation of cavernous smooth muscle by reducing local NO production. Arginase enzymes compete with the nitric oxide synthases for the common substrate, the amino acid l-arginine. Very little data are available regarding the significance of arginase enzymes in the control of human penile erectile tissue. The aim of the present study was to elucidate the effects of drugs known to inhibit arginase activity on the relaxation of isolated human corpus cavernosum (HCC) and the production of cyclic GMP.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


Ischemin sodium salt

Ischemin sodium salt is the sodium form of ischemin, which is a potent CBP bromodomain inhibitor. It inhibits p53 interaction with CBP and alters post-translati...

CC-17368
(CAS: 1547162-41-3)

CC-17368, a hydroxyisoindole derivative, is a metabolites of pomalidomide and has potential activity in anticancer study like multiple myeloma.

RuBi-Glutamate

RuBi-Glutamate, a ruthenium-bipyridine-trimethylphosphine caged glutamate, can be excited by visible wavelengths and releases glutamate after one- or two- photo...

CAS 947303-87-9 PF 429242

PF 429242
(CAS: 947303-87-9)

PF 429242 is a reversible, competitive, cell permeable inhibitor of sterol regulatory element-binding protein (SREBP) site 1 protease (IC50 = 0.175 μM) without ...

CAS 1416992-39-6 GC376

GC376
(CAS: 1416992-39-6)

GC376 is a 3CLpro inhibitor which is previously reported to be active against the 3CLpro of multiple coronaviruses, including SARS-CoV, but with highest potency...

CAS 40034-42-2 Rosoxacin

Rosoxacin
(CAS: 40034-42-2)

Rosoxacin. Rosoxacin is a 4-quinolone antibacterial with actions similar to those of nalidixic acid have antibacterial activity against Escherichia coli, Klebsi...

CAS 148505-03-7 GRK2i

GRK2i
(CAS: 148505-03-7)

GRK2i is a polypeptide inhibitor of GRK2 that specifically inhibits Gβγ activation of GRK2. GRK2i corresponds to the Gβγ-binding domain and acts as a cellular G...

CAS 17974-57-1 β-Apo-13-carotenone

β-Apo-13-carotenone
(CAS: 17974-57-1)

β-Apo-13-carotenone, also known as D'Orenone, a naturally occurring β-apocarotenoid, is an antagonist of RXRα.

Usistapide
(CAS: 403989-79-7)

Usistapide is a Microsomal triglyceride transfer protein inhibitor under development for the treatment of obesity and type 2 diabetes.

E-982
(CAS: 858102-78-0)

A1B1 hydrochloride

A1B1 hydrochloride is a potent and orally-available chemokine CCR1 antagonist.

CAS 916232-21-8 GS 143

GS 143
(CAS: 916232-21-8)

GS 143 is a β-TrCP1 ligase inhibitor. GS 143 exhibits inhibitory effects on IκBα ubiquitination (IC50 = 5.2 μM), LPS-induced expression of inflammatory cytokine...

CAS 3102-56-5 Dihydrosphingosine

Dihydrosphingosine
(CAS: 3102-56-5)

Dihydrosphingosine has been found to be a protein kinase C inhibitor as well as a novel activator of 3-Phosphinositide-dependent kinase 1.

CAS 388592-44-7 CK 869

CK 869
(CAS: 388592-44-7)

CK 869 has been found to inhibit actin polymerization as well as human and bovine actin-related protein 2/3 (Arp2/3) complex.

CAS 1354359-53-7 JW 480

JW 480
(CAS: 1354359-53-7)

JW 480 has been found to be a potent and selective inhibitor of KIAA1363 (AADACL1), which is a kind of serine hydrolase enzyme.

CAS 180977-44-0 GGTI-298

GGTI-298
(CAS: 180977-44-0)

GGTI-298 is a selective geranylgeranyltransferase type I inhibitor that displays little effect on other prenylation enzymes such as farnesyltransferase. GGTI-29...

CAS 120-51-4 Benzyl Benzoate

Benzyl Benzoate
(CAS: 120-51-4)

Benzyl benzoate, extracted from Cinnamomum zeylanicum leaves and stem bark, could be used as a pediculicide.

CAS 1579991-61-9 Chitinase-IN-1

Chitinase-IN-1
(CAS: 1579991-61-9)

Chitinase-IN-1 is a insect chitinase and N- acetyl hexosaminidase inhibitor and pesticide; 50 uM/20uM compound concentration's inhibitory percentage are 75%...

EED-226
(CAS: 2083627-02-3)

EED-226 is a novel allosteric Polycomb repressive complex 2 (PRC2) inhibitor (IC50 = 23.4 nM when the substrate is H3K27me0 peptide and IC50 = 53.5 nM when the ...

CAS 330203-01-5 TC HSD 21

TC HSD 21
(CAS: 330203-01-5)

TC HSD 21 is a potent 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) inhibitor (IC50 = 6 and 40 nM at human and mouse 17β-HSD3, respectively) with no activi...

Chemical Structure

CAS 1509-34-8 L-Allo-isoleucine

Quick Inquiry

Verification code

Featured Items